CING - Cingulate Inc.
3.94
-0.110 -2.792%
Share volume: 71,380
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$4.05
-0.11
-0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-08-2024 | 08-14-2023 | 11-13-2023 | 11-07-2024 | 05-08-2024 | 08-13-2024 | 11-07-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 3.850 M | 6.362 M | 5.750 M | 6.797 M | 2.948 M | 3.206 M | 3.282 M | 6.208 M | |
| Selling general and admin | 1.721 M | 1.906 M | 1.826 M | 1.812 M | 1.141 M | 1.325 M | 1.854 M | 1.880 M | |
| Research and development | 2.129 M | 4.456 M | 3.924 M | 4.985 M | 1.807 M | 1.881 M | 1.429 M | 4.329 M | |
| Total expenses | 3.850 M | 6.362 M | 5.750 M | 6.797 M | 2.948 M | 3.206 M | 3.282 M | 6.208 M | |
| 65.26% | -9.63% | 18.22% | -56.63% | 8.75% | 2.37% | 89.16% | |||
| Operating income | -3.850 M | -6.362 M | -5.750 M | -6.797 M | -2.948 M | -3.206 M | -3.282 M | -6.208 M | |
| Ebit | -3.850 M | -6.362 M | -5.750 M | -6.797 M | -2.948 M | -3.206 M | -3.282 M | -6.208 M | |
| Pretax income | -4.005 M | -6.616 M | -5.979 M | -6.935 M | -2.972 M | -3.210 M | -3.232 M | -6.132 M | |
| 65.21% | -9.63% | 15.98% | -57.14% | 7.98% | 0.68% | 89.75% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.005 M | -6.616 M | -5.979 M | -6.935 M | -2.972 M | -3.210 M | -3.232 M | -6.132 M | |
| -65.21% | 9.63% | -15.98% | 57.14% | -7.98% | -0.68% | -89.75% |
